Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00039741 · ClinicalTrials.gov registry record · Phase 2
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase 2 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 2
- Development phase
- 266
- Enrollment target
NCT00039741 is a Phase 2 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 266 participants.
The verdict
NCT00039741, a Phase 2 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 266 participants
- Enrollment target
Study Summary
Little is known about what treatment combinations are best for HIV infected children. This study examined the long-term effectiveness of different anti-HIV drug combinations in children and strategies for switching treatment if the first treatment does not work. The study enrolled children who had not previously taken anti-HIV medication. Participants in this study were recruited in the United States, South America and Europe. Some European children may also enroll in a substudy that will observe changes in body fat in children taking anti-HIV medications.
Interventions
- DRUG NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)
- DRUG NNRTIs (EFV, NVP)
- DRUG PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2002-08 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00039741
The ClinicalTrials.gov registry entry for NCT00039741 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT) is the first listed.
NCT00039741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00039741 about?
NCT00039741 is a clinical study titled "Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children". Little is known about what treatment combinations are best for HIV infected children. This study examined the long-term effectiveness of different anti-HIV drug combinations in children and strategies for switching treatment if the first treatment does not work. The study enrolled children who had n...
What is the current status of trial NCT00039741?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 266 participants. The study started on 2002-08. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00039741?
The interventions under investigation include: NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT) (DRUG), NNRTIs (EFV, NVP) (DRUG), PIs (AMP, IDV, LPV/r, NFV, SQV, RTV) (DRUG).
Who is sponsoring clinical trial NCT00039741?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.